ADHD and Cannabis: What the Research Actually Shows

Why this is complicated

Cannabis is the most commonly used substance among adults with ADHD aside from caffeine and nicotine. Lee et al. (2011) found that young adults with ADHD were 1.5 times more likely to develop a cannabis use disorder than their non-ADHD peers. Yet research on the specific interaction between cannabis and ADHD is remarkably sparse — partly because cannabis's legal status has historically made clinical trials difficult.

What follows is what the available evidence says. It's incomplete. It will evolve. Talk to your doctor about your specific situation.

What people report using it for

In surveys, adults with ADHD commonly report using cannabis for:

• Sleep — particularly difficulty "turning off" at night. See ADHD sleep problems.
• Anxiety reduction — calming racing thoughts
• "Slowing down" — reducing hyperactivity and restlessness
• Emotional regulation — managing frustration and irritability

Mitchell et al. (2019) surveyed adults with ADHD who use cannabis and found that 25% reported using it specifically for ADHD symptoms. However, self-reported benefit doesn't necessarily mean objective improvement — particularly because cannabis affects the subjective experience of time and attention in ways that can feel like improvement while measurably impairing performance.

What the science says so far

On attention and executive function: Cannabis impairs working memory, attention, and processing speed acutely (while intoxicated). Broyd et al. (2016) reviewed the neurocognitive effects and found that THC specifically impairs the exact executive functions that are already compromised in ADHD. The question is whether chronic, low-dose use has different effects — and we don't have good data yet.

On dopamine: This is where it gets neurochemically interesting. THC initially stimulates dopamine release. However, Bloomfield et al. (2016) found that chronic cannabis use is associated with reduced dopamine synthesis capacity in the striatum. For a brain that already has dopamine deficiency (the core ADHD neurochemical issue), chronic cannabis use could theoretically worsen baseline dopamine function over time.

On medication interaction: Loflin et al. (2014) noted that cannabis use among ADHD patients may counteract some medication benefits and complicates clinical assessment — it becomes harder for your prescriber to determine whether medication is working when cannabis is introducing its own neurochemical effects.

CBD specifically: One small, randomized controlled trial by Cooper et al. (2017) tested Sativex (THC:CBD 1:1) for adult ADHD and found a non-significant trend toward improvement in hyperactivity/impulsivity but no improvement in inattention. This is the only RCT to date, and it used a THC-containing product, so it tells us little about CBD alone.

The risk picture

• Substance use vulnerability: ADHD independently increases risk for substance use disorders. Adding cannabis doesn't help this equation. Chang et al. (2014) showed that stimulant treatment actually reduces substance use risk in ADHD — the opposite direction from adding cannabis.
• Adolescent/young adult brain development: The strongest evidence for cannabis harm is in brains under 25, where it may affect prefrontal cortex development. Since ADHD already involves prefrontal differences, this population may be particularly vulnerable.
• Cannabis use disorder: ADHD increases the risk of progressing from use to problematic use. The impulsivity component of ADHD may make it harder to regulate consumption.

If you currently use cannabis and have ADHD

This article is not telling you to stop. That's between you and your healthcare provider. What the research suggests:

• Be honest with your prescriber. They need accurate information to manage your treatment. Many providers are pragmatic about cannabis use — they'd rather know than not know.
• If you're starting medication, consider reducing or stopping cannabis for 2–4 weeks during titration so you and your doctor can get a clean read on how the medication works. You can always resume later, but the titration period is a poor time for confounding variables.
• Track your patterns. If you use cannabis, notice whether it actually helps specific symptoms or whether you're self-medicating discomfort that could be addressed through treatment adjustment. UpOrbit's tracking can help document patterns.

References

• Lee et al. (2011). ADHD and cannabis use disorder prevalence. Clin Psychol Rev.
• Mitchell et al. (2019). Self-reported cannabis use in adults with ADHD. Subst Use Misuse.
• Broyd et al. (2016). Neurocognitive effects of cannabis. Biol Psychiatry.
• Bloomfield et al. (2016). Cannabis and dopamine synthesis. Nature, 539(7629).
• Loflin et al. (2014). Cannabis and ADHD treatment. Subst Use Misuse, 54(13).
• Cooper et al. (2017). Cannabinoid RCT for ADHD. Eur Neuropsychopharmacol, 27(8).